Chemokines in autoimmune diseases

Immunological Reviews

Volumn 177, Issue , 2000, Pages 43-51

  Arimilli, S ^a   Ferlin, W ^a   Solvason, N ^a   Deshpande, S ^a   Howard, M ^a   Mocci, S ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL MIGRATION; CONTROLLED STUDY; HOST CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; TH1 CELL;

EID: 0033659468     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17716.x     Document Type: Review

References (78)

1. Natural killer cell stimulatory factor (interleukin 12, IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
2. Interleukin- 12 and its role in the generation of Th1 cells
3. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones
4. + T cell subsets: Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro
5. Generation and in vitro persistence of polarized Th1 and Th2 memory cells
6. + T cells, analyzed at the single-cell level
7. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10
8. Prevention of experimental autoimmune encephalomyelitis by antibodies against, interleukin 12
9. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes
10. Interleukin 4 reverses T ceil proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
11. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
12. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft
13. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
14. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
15. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis
16. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
17. The adhesion molecule and cytokine profile of multiple sclerosis lesions
18. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases
19. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
20. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells
21. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V β usage
22. The T lymphocyte in experimental allergic encephalomyelitis
23. + T cells in the pathogenesis of organ-specific autoimmune diseases
24. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis
25. + T-cell subsets in autoimmunity
26. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis
27. + T cell clones in the rat. Cloning methodology and interferon-γ secretion
28. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression
29. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse
30. Mice with a disrupted IFN-γ gent are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
31. Pathologic anatomy of the pancreas in juvenile diabetes mellitus
32. The pancreatic islets in diabetes
33. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: Insulin content of islets, insulitis and associated changes in the exocrine acinar tissue
34. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: A 25 year review of deaths in patients under 20 years of age in the United Kingdom
35. Autoimmune diabetes: Caught in the causality trap?
36. The role of T-cells in the development of autoimmune diabetes
37. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
38. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation
39. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice
40. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice
41. T helper cell subsets in insulin-dependent diabetes
42. Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis
43. Immune regulation in type 1 diabetes
44. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice
45. Diabetogenic T-cell clones
46. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice
47. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse
48. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice
49. Properties of the novel proinflammatory supergene 'intercrine' cytokine family
50. Chemokine receptors: Gateways to inflammation and infection
51. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
52. The pro-inflammatory seven-transmembrane segment receptors of the leukocyte
53. The molecular biology of leukocyte chemoattractant receptors
54. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP- 1 in experimental autoimmune encephalomyelitis
55. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
56. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells
57. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study
58. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glial and inflammatory cells in multiple sclerosis lesions
59. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
60. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
61. Do chemokines mediate leukocyte recruitment in posttraumatic CNS inflammation?
62. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury
63. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis
64. Chemokine expression in murine experimental allergic encephalomyelitis
65. Chemokines in neurological disease models: Correlation between chemokine expression patterns and inflammatory pathology
66. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T Iymphocytes and promotes T cell adhesion to endothelial cells
67. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
68. Mig and IP-10: CXC chemokines that target lymphocytes
69. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of Lewis rat
70. Activation of dual T cell signaling pathways by the chemokine RANTES
71. Chemokine receptors and T cell chemotaxis
72. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
73. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells
74. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
75. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
76. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes
77. IP-10, a -C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo
78. Identification of core structure and critical T cell receptor contact residues in an antigenic peptide by measuring acidification rates